Hypopyon uveitis following panretinal photocoagulation in a diabetic patient.
We report the case of a 42-year-old man with uncontrolled diabetes mellitus who presented to us with diminution of vision in both eyes for the past two years. On examination, both eyes showed features of high-risk proliferative diabetic retinopathy and the patient was advised of panretinal photocoagulation (PRP). He underwent the first sitting of PRP in both eyes. On the following day, he developed hypopyon uveitis in the right eye. He was treated with topical steroid and cycloplegic, and complete resolution of hypopyon was achieved over the next three days. This case highlights the importance of adequately controlled diabetes mellitus before PRP. Hypopyon uveitis could be a complication of PRP in patients with uncontrolled diabetes mellitus who respond to frequent topical steroid and cycloplegic.
Srimati. Kanuri Santhamma Centre for Vitreo-Retinal Diseases, Hyderabad Eye Research Foundation, Kallam Anji Reddy Campus, L. V. Prasad Eye Institute , Hyderabad , India.
Manish Kumar
MK
Sinha
Raja
R
Narayanan
Jay Kumar
JK
Chhablani
D000328:Adult; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D000068258:Bevacizumab; D003930:Diabetic Retinopathy / Q000601:surgery*; D004359:Drug Therapy, Combination; D005451:Fluorescein Angiography; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D017075:Laser Coagulation / Q000009:adverse effects*; D008297:Male; D011239:Prednisolone / Q000031:analogs & derivatives / Q000627:therapeutic use; D012160:Retina / Q000601:surgery*; D041623:Tomography, Optical Coherence; D014605:Uveitis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*
D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D005938:Glucocorticoids; D000068258:Bevacizumab; C009022:prednisolone phosphate; D011239:Prednisolone